IL-15 demonstrated efficacy in murine models of cancer [67] whilst studies in Macaques have demonstrated large increases in Tem CD8+ T-cell numbers [68], providing a rationale for its use as an alternative to IL-2. This evidence concerns the gene CD8A and cancer.